
Montelukast
Asthma, Allergic Rhinitis
4 · 5 · 10mg
Montelukast 4, 5 and 10 mg tablets, a leukotriene blocker for asthma prevention and hay fever, the ingredient in Singulair.
Montelukast (Singulair) represents a maintenance medication used to manage chronic respiratory symptoms. By blocking substances that lead to airway constriction, the active compound enables easier breathing for those with persistent conditions. Available formulations are listed below.

Asthma, Allergic Rhinitis
4 · 5 · 10mg
Montelukast 4, 5 and 10 mg tablets, a leukotriene blocker for asthma prevention and hay fever, the ingredient in Singulair.
Leukotriene receptor antagonists serve as a key component for long-term respiratory management. Targeted chemical pathways in your body contribute to airway inflammation when triggered by external factors. Multiple brands and forms allow patients to align their treatment with personal requirements and daily routines.
Montelukast usage centers on the prevention of symptoms related to Asthma. Physicians also apply this treatment to address Allergic Rhinitis, reducing common triggers like nasal congestion or persistent sneezing. Sustained use is typical for maintaining control over chronic inflammatory responses in the upper and lower respiratory tracts.
Blocking leukotriene receptors constitutes the primary mechanism of action for this medication. Leukotrienes are chemicals your body releases during allergic reactions or exercise, causing the airways in your lungs to swell and tighten. By disrupting this pathway, the medication maintains open airways and diminishes the frequency of respiratory distress during daily activities.
Generic versions alongside the originator brand Singulair provide alternative choices for those seeking specific administration formats. Choosing between a chewable tablet or a standard film-coated tablet often relies on swallowing preferences or ease of intake. All listed formulations fall under the Respiratory Health category for straightforward navigation and comparison.
Verify your medical history, particularly any known hypersensitivity to the active compound or other components in the formulation. Chronic conditions, such as liver disorders, require specific assessment before initiating a new maintenance medication.
Common responses often involve minor events like headache or increased respiratory congestion. While less frequent, mood changes or digestive discomfort sometimes occur. Abrupt discontinuation of management plans is discouraged without prior oversight.
Alcohol and certain concurrent medications may alter how your system processes this compound. Chronic conditions and standard clinical markers can influence the suitability of daily administration.
Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.
Last updated